Effectiveness of Care in Certified Cancer Centres in Germany (WiZen)

Technische Universität Dresden

Status: Completed

Conditions: Endometrial Cancer; Breast Cancer; Bronchial Cancer; Ovarian Cancer; Prostate Cancer; CNS Tumor; Pancreatic Cancer; Head and Neck Tumor; Cervix Cancer; Colorectal Cancer

Treatments: Other: Oncological certification

Study type: Observational

Funder types: Other

Identifiers

NCT04334239

01VSF17020

Details and patient eligibility

About

Assessment of the effectiveness of care in certified cancer centres for eight cancer entities via a retrospective cohort study based on secondary data from statutory health insurance funds and population-based clinical cancer registries.

Full description

Cancer constitutes the second most frequent cause of death in Germany. To maintain a high quality of treatment, the national cancer plan aims at a unified certification of cancer centres.

The project "Wirksamkeit der Versorgung in onkologischen Zentren" (WiZen) investigates effects of treatments in certified cancer centres across large populations and different cancer entities in comparison to hospitals that do not hold a certificate.

WiZen is a retrospective comparative cohort study that analyzes incident cases of eight types of cancer diagnosed within 2009-2017 based on nationwide health insurance data provided by WIdO (the AOK research institute) and data from regional clinical cancer registries (CCR) for the period 2006-2017. These eight types of cancer are colorectal cancer, pancreatic cancer, breast cancer, gynecologic tumors, lung cancer, prostate cancer, head and neck tumors and neuro-oncological tumors.

Enrollment: 670,000 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• first hospitalization due to diagnosis of colorectal cancer, pancreatic cancer, breast cancer, gynecologic tumors, lung cancer, prostate cancer, head and neck tumors, or neuro-oncological tumors 2009-2017 [WIdO]
• hospitalization due to primary diagnosis of colorectal cancer, pancreatic cancer, breast cancer, gynecologic tumors, lung cancer, prostate cancer, head and neck tumors, or neuro-oncological tumors 2006-2017 [CCR]

Exclusion criteria

• prevalent diagnosis of colorectal cancer, pancreatic cancer, breast cancer, gynecologic tumors, lung cancer, prostate cancer, head and neck tumors, or neuro-oncological tumors 2006-2017
• exception: outpatient cancer diagnosis up to 12 months prior to first hospitalization is not regarded as prevalent

Trial design

670,000 participants in 2 patient groups

Intervention

Description:

Cancer patients who have undergone substantial parts of inpatient treatment in a certified cancer centre.

Treatment:

Other: Oncological certification

Control

Description:

Cancer patients who have not undergone inpatient treatment in a certified cancer centre.